Sichuan Hexie Shuangma Co., Ltd. (SHE:000935)
21.29
+0.09 (0.42%)
Aug 3, 2026, 3:04 PM CST
Sichuan Hexie Shuangma Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,148 | 1,206 | 1,075 | 1,219 | 1,220 | 1,224 |
Revenue Growth | -3.25% | 12.19% | -11.87% | -0.02% | -0.34% | -16.90% |
Gross Profit Gross Profit Growth | 447.03 | 459.6 | 492.45 | 619.05 | 512.13 | 593.77 |
Operating Income Operating Income Growth | 177.3 | 196.48 | 337.67 | 458.72 | 321.02 | 407.58 |
Net Income Net Income Growth | 240.52 | 298.28 | 309.38 | 985.47 | 825.12 | 988.73 |
Earnings Per Share EPS Growth | 0.44 | 0.54 | 0.95 | 1.29 | 1.08 | 1.30 |
EPS Growth | -67.89% | -43.16% | -26.36% | 19.44% | -16.92% | 12.07% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Biopharmaceutical Business Division Biopharmaceutical Business Division Growth | 280.14 | 28.52 | - | - | - |
Building Materials Business Building Materials Business Growth | 544.88 | 593.98 | 753.65 | 946.48 | 930.4 |
Private Equity Investment Management Business Segment Private Equity Investment Management Business Segment Growth | 380.49 | 452.06 | 465.7 | 273.1 | 293.41 |
Total Total Growth | 1,206 | 1,075 | 1,219 | 1,220 | 1,224 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 582.55 | 560.59 | 340.15 | 1,282 | 684.49 | 1,142 |
Total Debt Total Debt Growth | 1,045 | 999.74 | 625.95 | 21.22 | 58.61 | 42.29 |
Net Cash (Debt) Net Cash Growth | -462.01 | -439.15 | -285.8 | 1,261 | 625.88 | 1,100 |
Net Cash Growth | - | - | - | 101.45% | -43.08% | -22.71% |
Net Cash Per Share Net Cash Per Share Growth | -0.85 | -0.80 | -0.88 | 1.65 | 0.82 | 1.45 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 268.48 | 321.5 | 462.92 | 309.27 | 413.92 | 441.22 |
Capital Expenditures CapEx Growth | -117.36 | -65.31 | -58 | -25.28 | -67.61 | -101.73 |
Free Cash Flow Free Cash Flow Growth | 151.12 | 256.2 | 404.91 | 283.99 | 346.31 | 339.49 |
Free Cash Flow Growth | -61.04% | -36.73% | 42.58% | -17.99% | 2.01% | -33.23% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 38.94% | 38.13% | 45.83% | 50.77% | 41.99% | 48.52% |
Operating Margin | 15.45% | 16.30% | 31.42% | 37.62% | 26.32% | 33.30% |
Pretax Margin | 25.15% | 29.10% | 26.53% | 92.64% | 76.19% | 93.19% |
Profit Margin | 20.95% | 24.74% | 28.79% | 80.82% | 67.66% | 80.79% |
FCF Margin | 13.16% | 21.25% | 37.68% | 23.29% | 28.40% | 27.74% |
| Fiscal Year | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Period Ending | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.340 | - | 0.240 |
Dividend Per Share Growth | - | - | 14.29% |
Dividend Yield | 1.94% | - | 1.02% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 47.96 | 63.06 | 35.44 | 13.88 | 19.43 | 18.76 |
Forward PE | - | 7.70 | 7.70 | 7.70 | 9.40 | 14.95 |
P/FCF Ratio | 106.68 | 73.42 | 27.08 | 48.17 | 46.30 | 54.65 |
PS Ratio | 14.04 | 15.60 | 10.20 | 11.22 | 13.15 | 15.16 |